特一药业
(002728)
| 流通市值：32.96亿 | | | 总市值：50.97亿 |
| 流通股本：3.32亿 | | | 总股本：5.13亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 140,329,496.83 | 126,153,962.89 | 215,398,408.79 | 286,258,083.96 |
| 交易性金融资产 | 225,000,000 | 210,000,000 | 100,000,000 | 75,000,000 |
| 应收票据及应收账款 | 146,357,775.86 | 174,806,916.35 | 155,467,029.61 | 139,559,816.8 |
| 其中：应收票据 | 93,210,987.46 | 100,811,983.44 | 82,672,975.5 | 71,589,420.53 |
| 应收账款 | 53,146,788.4 | 73,994,932.91 | 72,794,054.11 | 67,970,396.27 |
| 应收款项融资 | 88,033,959.36 | 78,779,997.45 | - | - |
| 预付款项 | 27,214,316.35 | 16,030,065.81 | 24,586,702.76 | 19,695,486.14 |
| 其他应收款合计 | 810,552.84 | 804,927.23 | 894,943.2 | 1,211,196.25 |
| 存货 | 256,908,410.91 | 237,625,580.45 | 259,601,855.05 | 286,205,647.15 |
| 其他流动资产 | 7,198,071.89 | 13,398,187.69 | 7,927,814.41 | 8,628,164.78 |
| 流动资产合计 | 891,852,584.04 | 857,599,637.87 | 763,876,753.82 | 816,558,395.08 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 13,500,000 | 13,500,000 | 13,500,000 | 13,500,000 |
| 投资性房地产 | 8,534,206.6 | 8,655,739.69 | 8,777,291.25 | 8,898,818.19 |
| 固定资产 | 600,702,005.19 | 614,929,386.12 | 532,612,863.51 | 541,588,272.18 |
| 在建工程 | 121,242,546.38 | 118,383,066.38 | 196,969,581.75 | 184,645,723.95 |
| 无形资产 | 137,716,066.55 | 141,218,072.57 | 135,804,482.97 | 139,074,849.07 |
| 开发支出 | 9,015,874.06 | 7,292,166.42 | 16,958,926.44 | 16,551,926.44 |
| 商誉 | 517,600,671.3 | 517,600,671.3 | 517,600,671.3 | 517,600,671.3 |
| 递延所得税资产 | 21,327,093.62 | 28,431,125.87 | 20,777,016.97 | 18,713,397.13 |
| 其他非流动资产 | 6,605,958.05 | 3,818,639.12 | 13,728,588.39 | 17,634,065.85 |
| 非流动资产合计 | 1,436,244,421.75 | 1,453,828,867.47 | 1,456,729,422.58 | 1,458,207,724.11 |
| 资产总计 | 2,328,097,005.79 | 2,311,428,505.34 | 2,220,606,176.4 | 2,274,766,119.19 |
| 流动负债: | | | | |
| 短期借款 | 288,575,418.3 | 263,543,566.1 | 260,000,000 | 310,000,000 |
| 应付票据及应付账款 | 69,634,500.99 | 68,625,753.39 | 67,644,996.08 | 86,892,756.98 |
| 其中：应付票据 | 17,895,387.79 | 13,594,946.31 | 17,630,178.59 | 15,839,387.42 |
| 应付账款 | 51,739,113.2 | 55,030,807.08 | 50,014,817.49 | 71,053,369.56 |
| 合同负债 | 43,606,323.89 | 62,180,482.56 | 23,572,574.43 | 21,105,271.52 |
| 应付职工薪酬 | 7,912,911.86 | 11,558,709.79 | 7,473,899.57 | 7,279,460.67 |
| 应交税费 | 7,015,713.73 | 18,695,112.91 | 15,446,419.05 | 6,996,508.76 |
| 其他应付款合计 | 9,265,073.17 | 16,889,241.82 | 3,235,767.81 | 28,236,395.48 |
| 应付股利 | - | - | - | 24,946,612.4 |
| 其他流动负债 | 17,615,730.13 | 12,841,702.15 | 3,058,262.45 | 2,737,513.06 |
| 流动负债合计 | 443,625,672.07 | 454,334,568.72 | 380,431,919.39 | 463,247,906.47 |
| 非流动负债: | | | | |
| 递延收益 | 18,884,436.37 | 17,270,471.54 | 18,084,221.19 | 18,897,894.07 |
| 递延所得税负债 | 18,303,351.14 | 18,357,464.58 | 19,154,780.86 | 19,209,390.4 |
| 非流动负债合计 | 37,187,787.51 | 35,627,936.12 | 37,239,002.05 | 38,107,284.47 |
| 负债合计 | 480,813,459.58 | 489,962,504.84 | 417,670,921.44 | 501,355,190.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 513,309,812 | 513,309,812 | 513,002,496 | 512,625,018 |
| 资本公积 | 849,967,726.06 | 849,967,726.06 | 848,260,589.44 | 846,299,636.22 |
| 减:库存股 | 101,192,257.35 | 101,192,257.35 | 101,192,257.35 | 101,192,257.35 |
| 专项储备 | 6,906,666.62 | 6,852,362.63 | 6,790,555.32 | 6,814,059.74 |
| 盈余公积 | 153,130,147.47 | 153,130,147.47 | 142,309,314.62 | 142,309,314.62 |
| 未分配利润 | 425,161,451.41 | 399,398,209.69 | 393,764,556.93 | 366,555,157.02 |
| 归属于母公司股东权益合计 | 1,847,283,546.21 | 1,821,466,000.5 | 1,802,935,254.96 | 1,773,410,928.25 |
| 股东权益合计 | 1,847,283,546.21 | 1,821,466,000.5 | 1,802,935,254.96 | 1,773,410,928.25 |
| 负债和股东权益合计 | 2,328,097,005.79 | 2,311,428,505.34 | 2,220,606,176.4 | 2,274,766,119.19 |
| 公告日期 | 2026-04-28 | 2026-03-24 | 2025-10-24 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |